-
Living Donor Liver Transplantation for High MELD Score Patients
-
Living Kidney Donor Consent: Compliance with CMS & OPTN Requirements
-
Locally-Delivered CD4+CD25highFoxp3+ Regulatory T Cells Combined with Systemic KRP203 Therapy Induces Tolerance to Islet Allografts
-
Long Term (5-Year) Outcomes Using Subcutaneous Alemtuzumab for Induction in Highly-HLA-Sensitized (HS) Kidney Transplant Recipients
-
Long Term Clinical Outcome of Liver Transplant Recipients Who Successfully Withdrawn Immunosuppression, The
-
Long Term Outcomes and Quality of Life of Live Liver Donors. A Single Center Experience
-
Long Term Outcomes of Highly-HLA Sensitized (PRA>80%) (HS) Patients Receiving Desensitization with IVIG or IVIG + Rituximab: A Retrospective, Single-Center Analysis
-
Long Term Outcomes of Incidentally Discovered Hepatocellular Carcinoma
-
Long Term Outcomes of Treatment for Vascular Complication Following Living Donor Liver Transplantation: The Efficacy of Stent Placement
-
Long Term Outcomes of Young (< 18 Years) Kidney Donors: A Matched Cohort Analysis
- « Previous Page
- 1
- …
- 99
- 100
- 101
- 102
- 103
- …
- 178
- Next Page »